- Report
- April 2024
- 185 Pages
Global
From €4693EUR$4,900USD£3,997GBP
- Report
- January 2024
- 185 Pages
Global
From €4693EUR$4,900USD£3,997GBP
- Report
- October 2023
- 189 Pages
Global
From €4693EUR$4,900USD£3,997GBP
- Report
- July 2023
- 114 Pages
Global
From €4310EUR$4,500USD£3,670GBP
- Report
- December 2023
- 149 Pages
Global
From €4262EUR$4,450USD£3,630GBP
- Report
- July 2023
- 145 Pages
Global
From €3017EUR$3,150USD£2,569GBP
- Report
- January 2024
Global
From €3448EUR$3,600USD£2,936GBP
- Report
- January 2024
- 170 Pages
Global
€4784EUR$4,995USD£4,074GBP
- Report
- October 2023
- 128 Pages
Europe
From €4214EUR$4,400USD£3,589GBP
- Report
- February 2024
- 90 Pages
North America
From €4550EUR$4,750USD£3,874GBP
- Report
- December 2023
- 92 Pages
North America
From €3592EUR$3,750USD£3,059GBP
- Report
- January 2024
Asia Pacific
From €1437EUR$1,500USD£1,223GBP
- Report
- February 2021
- 256 Pages
Global
From €4596EUR$4,799USD£3,914GBP
- Report
- January 2023
- 270 Pages
Global
From €4596EUR$4,799USD£3,914GBP
- Report
- July 2020
- 283 Pages
Global
From €4692EUR$4,899USD£3,996GBP
- Report
- August 2018
- 422 Pages
Global
From €4310EUR$4,500USD£3,670GBP
- Report
- March 2022
- 933 Pages
Global
From €2931EUR$3,060USD£2,496GBP
€3448EUR$3,600USD£2,936GBP
- Clinical Trials
- July 2020
Global
From €2442EUR$2,550USD£2,080GBP
€2873EUR$3,000USD£2,447GBP
- Report
- November 2018
- 700 Pages
Global
From €1954EUR$2,040USD£1,664GBP
€2299EUR$2,400USD£1,958GBP
- Report
- March 2023
- 240 Pages
Global
From €4741EUR$4,950USD£4,037GBP
Targeted Drug Delivery System (TDDS) is a specialized area within the broader pharmacological field of Drug Delivery. TDDS aims to direct medication to specific cells, tissues, or organs, thereby increasing the concentration of the drug at the intended site of action while minimizing its presence in the rest of the body. This method potentially reduces side effects and enhances treatment efficacy. The market for these systems encompasses a wide range of technologies and platforms, such as nanoparticles, liposomes, and biodegradable polymers designed to release pharmaceutical compounds in a controlled manner. The field has been propelled by advances in biotechnology, nanotechnology, and molecular biology, which have contributed to the development of novel targeted drug delivery mechanisms. These include antibodies, receptor-mediated delivery systems, and gene-delivery vectors. TDDS is used in addressing various medical conditions, with cancer therapy being a particularly active area due to the need for precise drug delivery to tumor cells.
Several companies specialize in the research and development of Targeted Drug Delivery Systems, contributing to the maturation of this market. Some notable players in the field include Alkermes, BIND Therapeutics, DEPArray Technology, Genentech, Immunomedics, Inc., and Kite Pharma. These companies have a diverse product portfolio of targeted delivery technologies and are engaged in the development of innovative treatments for a wide range of diseases, striving to improve therapeutic outcomes and patient quality of life. Show Less Read more